Submitted:
12 February 2021
Posted:
15 February 2021
Read the latest preprint version here
Abstract
Theranostics covers combination of diagnostic and therapeutic techniques for various cancers throughout body using suitable drug combination. This review covers well-known treatment of thyroid cancer and pheochromocytoma with I-131 compounds and also new radiopharmaceuticals for prostatic cancer and pancreatic cancer. Of particular, new trends toward patient outcome has been focused. The theranostics will become an ever-increasing part of clinical nuclear medicine these days.
Keywords:
PET
; Theranostics
; Radiopharmaceuticals
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
